|
US12203938B2
(en)
|
|
Levetiracetam immunoassays
|
|
AU2005200717B2
(en)
|
|
2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses
|
|
US9095557B2
(en)
|
|
Anticonvulsant combination therapy
|
|
JP2025102814A
(en)
|
|
Compositions and methods for regulating hair growth
|
|
US20180125818A1
(en)
|
|
Methods and compositions for treating schizophrenia
|
|
AU2002340971A1
(en)
|
|
Use of 2-oxo-1-pyrrolidine derivatives for the treatment of dyskinesia and movement disorders
|
|
US20090131508A1
(en)
|
|
Use of 2-Oxo-1-Pyrrolidone Derivatives for the Preparation of a Drug
|
|
EP2968220A4
(en)
|
|
METHODS AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION
|
|
CN109932442A
(en)
|
|
A kind of detection method of Bu Waxitan isomers
|
|
KR20170007528A
(en)
|
|
Prolonged release formulations comprising an 2-oxo-1-pyrrolidine derivate
|
|
US12559456B2
(en)
|
|
Method for preparing levetiracetam and intermediates thereof
|
|
PL4036244T3
(en)
|
|
Enzymatic process for the preparation of (2s)-2-[(4r)-2-oxo-4-propyl-pyrrolidin-1-yl]butyric acid and its conversion into brivaracetam
|
|
EP1619182A1
(en)
|
|
Substance exhibiting antidepressant property
|
|
RU2003110288A
(en)
|
|
ANTI-PRESSIVE SUBSTANCE
|
|
RU2699669C1
(en)
|
|
Novel compositions of n-carbamoylmethyl-4-phenyl-2-pyrrolidone
|
|
US20240409511A1
(en)
|
|
Process for the production of levetiracetam and intermediates thereof
|
|
JP6453632B2
(en)
|
|
Cyclic amide acrylate-containing composition and method for producing the same
|